Memory and Hashimoto’s thyroiditis under levothyroxine treatment: is there a placebo or nocebo effect?
- 249 Downloads
According to numerous studies, chronic autoimmune Hashimoto’s thyroiditis (HT) is the most common reported cause of hypothyroidism, which is considered to have detrimental effects on the brain, and consequently on one of the most important cognitive functions, namely memory; yet some research suggests that treatment of hypothyroidism, resulting in a return to euthyroidism in HT, may be associated with definite recovery of overall neurocognitive functioning .
Although healthy euthyroid middle-aged women, with higher levels of free triidothyronine (T3) and thyroglobulin antibodies (Anti-TG) levels, within the normal range, showed slower cognitive performance and more errors on neuropsychological tests of executive function , no research has not confirmed that euthyroidism under synthetic levothyroxine (LT4) treatment leads to serious neuropsychological deficits (e.g. in immediate recall, delayed recall, verbal learning, inhibitory efficiency, information processing...
The author would like to thank Jennifer A. McCabe, PhD for her support with the English language editing of the text.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interest.
All procedures performed in this study involving human participants were in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments.
Informed consent was obtained from all individual participants included in the study.
- 4.A.K. Shapiro, L.A. Morris, The placebo effect in medical and psychological therapies. In In: S.L. Garfield, A.E. Bergin (eds) Handbook of psychotherapy and behavior change , pp. 369–409. Wiley, New York, NY (1978)Google Scholar